Abstract:Background: Contrast-enhanced MRI is the best imaging modality for liver tumor detection and differential diagnosis. However, it is long scan times required and has the contrast agent-associated risks. This study aims to develop and validate a deep convolutional neural network for initial diagnosis of liver tumors based on non-contrast MRI. Methods: In total, 50418 images in enhanced MRI from 1959 patients with liver tumor in three center were enrolled. T2-weighted imaging, diffusion-weighted imaging (DWI), and multiphasic T1-weighted imaging provided input for Inception-ResNet V2 through transfer learning to generate four models for three-way classification. The models was then validated on the independent internal and two external datasets consisting of 5172 and 2916,1338 images, respectively. The diagnostic performance of non-contrast models(T2, T2+DWI) for distinguishing malignancy from benign tumors at-patient level were further evaluated in three validation sets. Findings: Non-contrast models demonstrated similar performance for classifying liver tumors to benign, primary malignant and metastatic tumors, compared with two models based on multi-sequence or enhanced images. In the independent internal cohort, the areas under the receiver operating characteristic curves of T2+DWI model reached 0.91(95% CI,0.888–0.932), 0.873(95% CI,0.848-0.899), and 0.876 (95% CI, 0.840-0.911) for three categories, respectively. At patient-level, the sensitivities of malignant tumors gained from non-contrast models reached 98.1%, 85.7%, 87.5% respectively in three validation sets, while all specificities were almost greater than 70%. Interpretation: This study demonstrates that based on non-contrast MRI, deep learning algorithm can correctly classify liver tumors into benign, primary malignant and metastatic tumors at image-level, and distinguish malignancy from benign with high sensitivity at patient-level, potentially reducing the number of enhanced testing to avoid side effects and financial costs. Funding Statement: This work was supported by grants from National Natural Science Foundation of China (81827804 to X.C.). Declaration of Interests: None. Ethics Approval Statement: This study was approved by the independent institutional review boards of three hospitals and performed according to the Helsinki declaration. The requirement for written informed consent was exempted because of the retrospective nature of this study.

Primary liver cancer classification from routine tumour biopsy using weakly supervised deep learning

Classification of Focal Liver Lesions Using Deep Learning with Fine-Tuning

Deep Neural Network-Based Classification of Focal Liver Lesions Using Phase-Shuffle Prediction Pre-training

Residual Convolutional Neural Networks With Global And Local Pathways For Classification Of Focal Liver Lesions

Deep Learning for Accurate Diagnosis of Liver Tumor Based on Magnetic Resonance Imaging and Clinical Data

Deep Learning-Based Classification of Hepatocellular Nodular Lesions on Whole-Slide Histopathologic Images

Automatic Detection and Classification of Focal Liver Lesions Based on Deep Convolutional Neural Networks: A Preliminary Study

Automated Detection of Primary Liver Cancer Using Different Deep Learning Approaches

Deep Learning-Based Classification of Liver Cancer Histopathology Images Using Only Global Labels.

Deep Learning-Assisted Diagnosis of Liver Tumors Using Non-Contrast Magnetic Resonance Imaging: A Multi-Center Study

Deep learning-based phenotyping reclassifies combined hepatocellular-cholangiocarcinoma

Hybrid deep learning-based strategy for the hepatocellular carcinoma cancer grade classification of H&E stained liver histopathology images

Classification and Mutation Prediction Based on Histopathology H&E Images in Liver Cancer Using Deep Learning.

A multi-modal deep neural network for multi-class liver cancer diagnosis

Automated machine learning for differentiation of hepatocellular carcinoma from intrahepatic cholangiocarcinoma on multiphasic MRI

An automated liver tumour segmentation and classification model by deep learning based approaches

Deep Learning Facilitates Distinguishing Histologic Subtypes of Pulmonary Neuroendocrine Tumors on Digital Whole-Slide Images

Deep Learning Classification and Quantification of Pejorative and Nonpejorative Architectures in Resected Hepatocellular Carcinoma from Digital Histopathologic Images

Impact of a deep learning assistant on the histopathologic classification of liver cancer

Deep learning for prediction of hepatocellular carcinoma recurrence after resection or liver transplantation: a discovery and validation study

Deep Learning-Enabled Diagnosis of Liver Adenocarcinoma